Micro-ecology restoration of colonic inflammation by in-Situ oral delivery of antibody-laden hydrogel microcapsules.
Micro-ecology restoration of colonic inflammation by in-Situ oral delivery of antibody-laden hydrogel microcapsules.
复制标题
通过原位口服负载抗体的水凝胶微胶囊来恢复结肠炎症的微生态
DOI:
10.1016/j.bioactmat.2021.12.022
复制
发表时间:
2022-09
影响因子:
18.9
通讯作者:
Wu Z
中科院分区:
文献类型:
--
作者:
Li B;Li X;Chu X;Lou P;Yuan Y;Zhuge A;Zhu X;Shen Y;Pan J;Zhang L;Li L;Wu Z
In-situ oral delivery of therapeutic antibodies, like monoclonal antibody, for chronic inflammation treatment is the most convenient approach compared with other administration routes. Moreover, the abundant links between the gut microbiota and colonic inflammation indicate that the synergistic or antagonistic effect of gut microbiota to colonic inflammation. However, the antibody activity would be significantly affected while transferring through the gastrointestinal tract due to hostile conditions. Moreover, these antibodies have short serum half-lives, thus, require to be frequently administered with high doses to be effective, leading to low patient tolerance. Here, we develop a strategy utilizing thin shell hydrogel microcapsule fabricated by microfluidic technique as the oral delivering carrier. By encapsulating antibodies in these microcapsules, antibodies survive in the hostile gastrointestinal environment and rapidly release into the small intestine through oral administration route, achieving the same therapeutic effect as the intravenous injection evaluated by a colonic inflammation disease model. Moreover, the abundance of some intestinal microorganisms as the indication of the improvement of inflammation has remarkably altered after in-situ antibody-laden microcapsules delivery, implying the restoration of micro-ecology of the intestine. These findings prove our microcapsules are exploited as an efficient oral delivery agent for antibodies with programmable function in clinical application. Orally Administered Antibody-laden Core-shell Microcapsules for Colonic Inflammation. The core-shell microcapsules release antibodies in the colonic lumen, and reduce the inflammable reaction, thereby recreate the balance of intestinal microbiota. This thin shell hydrogel microcapsules using a water-in-water-in-oil as the template by microfluidic technique for orally delivery of antibodies is generated to protect from hostile stomach microenvironment and rapid released in the small intestine without losing their activity. The shell contains a double crosslinked network attributed to its ionic crosslinking and covalent crosslinking functionalities. The antibody-laden microcapsules demonstrate great therapeutic efficacy in DSS-induced colonic inflammation disease models, which is approximated to that of the intravenous injection treatment. Orally taken antibody-laden microcapsules restore the intestinal micro-ecological dysbiosis. The thin shell hydrogel microcapsules using a water-in-water-in-oil as the template by microfluidic technique for orally delivery of antibodies is generated to protect from hostile stomach microenvironment and rapid released in the small intestine without losing their activity.
登录
查看更多内容
影响因子:
4.4
作者:
Li, PC;Makarov, DE
通讯作者:
Makarov, DE
影响因子:
3.8
作者:
Damge, Christiane;Socha, Marie;Maincent, Philippe
通讯作者:
Maincent, Philippe
影响因子:
41.2
作者:
Lee, Yonghyun;Sugihara, Kohei;Moon, James J.
通讯作者:
Moon, James J.
影响因子:
14
作者:
Edelman, ER;Nathan, A;Karnovsky, MJ
通讯作者:
Karnovsky, MJ
影响因子:
28.1
作者:
Lamson, Nicholas G.;Berger, Adrian;Whitehead, Kathryn A.
通讯作者:
Whitehead, Kathryn A.